Buy Crypto Markets Spot FuturesBTC Earn Event Center Rewards Hub

TG Therapeutics, Inc. (TGTX)

NASDAQ

$55,97

$-0,05

(-0,10%)

TG Therapeutics, Inc. (TGTX) Live Price Chart

Last updated: ⁦2026-08-25 17:08:20⁩. Stock price data is sourced from Massive.

Key Market Data

Market Cap	$8,31B
Open	$56,66
High	$59,30
Low	$2,97
Previous Close	$56,01
Price Change	$-0,05
Percentage Change	-0,10%
Volume	849K

TG Therapeutics, Inc. (TGTX) Stock Price Today

TG Therapeutics, Inc. (TGTX) is currently trading at $55,97 as of 2026-08-25 17:08:00, reflecting a -0,10% move ($-0,05) from the previous close.

In the short term, the stock has returned +0,39% over the past four weeks. Over the last 12 months, TG Therapeutics, Inc. has recorded a +96,18% price change, indicating a Strong performance relative to the broader market.

TG Therapeutics, Inc. (TGTX) 7-Day Stock Price Changes

Over the past seven days, TG Therapeutics, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $51,62 to the latest recorded price of $55,97, reflecting an intraday change of -0,10%. Daily movements highlight shifts in trading volume (848.632), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, TGTX has delivered a +0,39% return over the past month and a +96,18% change in the last 12 months, indicating a Strong trend relative to its broader sector peers.

How to Buy TG Therapeutics, Inc. (TGTX)

You can buy and trade TGTX on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for TGTX and Execute Your Trade

Open the trading page, enter TGTX in the search bar, select the amount of TGTX you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is TG Therapeutics, Inc. (TGTX)?

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

TG Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	399
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.tgtherapeutics.com

Frequently Asked Questions (FAQ)

1.Can I buy and sell U.S. stocks directly on MEXC right now?

Yes. MEXC supports direct trading of U.S. stocks in three ways: RealStocks (held via a regulated broker partner), Tokenized Stocks that trade 24/7 with self-custody, and Stock Futures with up to 200x leverage. You can fund a purchase with local currency or crypto, and manage all three product types from a single account.

2.What type of U.S. stocks can I trade on MEXC?

You can trade thousands of leading U.S. equities listed on major exchanges like the NYSE and NASDAQ, including tech giants like Apple (AAPL), Tesla (TSLA), and NVIDIA (NVDA), as well as newly listed IPOs. Availability varies by product type — RealStocks, Tokenized Stocks, and Stock Futures each carry their own list of supported tickers.

3.Are stock prices and trading data updated in real-time?

Yes. MEXC provides real-time pricing, 24-hour fluctuations, and market cap rankings across all three stock products, so your buy and sell decisions are based on live data, not delayed quotes.

4.Can I trade U.S. stocks 24/7, or only during market hours?

It depends on the product. RealStocks follow standard U.S. market hours (9:30 AM–4:00 PM ET, Monday–Friday). Tokenized Stocks and Stock Futures trade continuously, 24/7, letting you act on price moves even when traditional markets are closed.

5.Does MEXC charge commission on U.S. stock trading?

RealStocks trade commission-free. Tokenized Stocks and Stock Futures carry a small trading fee, among the lowest in the industry — currently as low as 0.00%/0.02% maker/taker on Stock Futures.

6.What does TGTX's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ 2,88 summarises how much profit TG Therapeutics, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track TG Therapeutics, Inc.'s financial performance over time?

To follow TG Therapeutics, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how TGTX is performing and how the market is responding.

8.When is TG Therapeutics, Inc. expected to report earnings?

TG Therapeutics, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for TGTX, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in TG Therapeutics, Inc.'s earnings reports?

TG Therapeutics, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether TGTX is meeting, beating or missing expectations.

10.How can I stay informed about TG Therapeutics, Inc.'s results and guidance?

You can stay up to date on TG Therapeutics, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for TGTX on this page helps you see how new information is being reflected in the stock.

11.Does TG Therapeutics, Inc. pay a regular cash dividend to its shareholders?

TG Therapeutics, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor TGTX's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for TGTX?

Based on the latest earnings data, TGTX has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether TG Therapeutics, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings TG Therapeutics, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is TG Therapeutics, Inc.?

TG Therapeutics, Inc. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is TGTX valued in terms of P/E ratio and EPS?

TG Therapeutics, Inc. currently trades at a price-to-earnings (P/E) ratio of 19,42, based on trailing-twelve-month earnings per share (EPS) of $ 2,88. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of TG Therapeutics, Inc.'s earnings. Comparing TGTX's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Progressive Corporation

PGR

ABT

NEE

Top Gainers

Browse today's leading gainers in the US stock market

707 Cayman Holdings Limited

JEM

Autonomix Medical, Inc.

AMIX

Swvl Holdings Corp.

SWVL

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

MEXC Aug 8: Share $500K

Refer friends early to earn 888% APR and $3,888

TGTX-to-USD Calculator

Amount

TGTX

USD

1 TGTX = 55,97 USD